{"id":"W4379645953","doi":"10.1200/jco.2023.41.17_suppl.lba500","title":"Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: Primary results from the phase III NATALEE trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Letrozole; Breast cancer; Clinical endpoint; Tolerability; Internal medicine; Anastrozole; Population; Oncology; Interim analysis; Goserelin; Cancer; Surgery; Gynecology; Randomized controlled trial; Tamoxifen; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002200267,0.0009156527,0.001391734,0.0003069431,0.000217242,0.0009104568,0.0006310215,0.0008791805,0.004128017],"category_scores_gemma":[0.001070071,0.0003220175,0.001106863,0.0003814317,0.0004370017,0.0006514746,0.0004192439,0.001706661,0.0008008242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007228742,"about_ca_system_score_gemma":0.001057977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008707976,"about_ca_topic_score_gemma":0.00541968,"domain_scores_codex":[0.9995703,0.0002613206,0.00002033135,0.00004205336,0.00003671753,0.00006918539],"domain_scores_gemma":[0.9995614,0.00008916509,0.0001159456,0.0000459272,0.000024917,0.000162626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8814989,0.0130335,0.006582703,0.001280918,0.002668606,0.0001363518,0.00008709149,0.002044265,0.008918284,0.0003386623,0.008264847,0.07514586],"study_design_scores_gemma":[0.8301743,0.1292258,0.02276908,0.0002001274,0.002721971,0.0002986956,0.00007879339,0.001185461,0.001952311,0.0005296652,0.01082429,0.00003949064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9458293,0.02664296,0.0009983727,0.00214768,0.0004536403,0.003732994,0.007528778,0.0001674958,0.01249889],"genre_scores_gemma":[0.9686331,0.007118971,0.001735577,0.002659147,0.0004416671,0.00445497,0.0083817,0.00005432507,0.006520533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004128017,"threshold_uncertainty_score":0.01380956,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07422391342854126,"score_gpt":0.4508825997255233,"score_spread":0.3766586862969821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}